Greenlight Biosciences Holdings Pbc Net Income per Employee (GRNA), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Greenlight Biosciences Holdings Pbc  (NASDAQ: GRNA)
 

Greenlight Biosciences Holdings Pbc Net Income per Employee

GRNA's Quarterly Results, Trends, Rankings, Statistics
Greenlight Biosciences Holdings Pbc recorded a cumulative net loss of $-157 million during 12 month ending in the first quarter 2023.
The Healthcare sector has seen employees of 76 other companies achieving higher income per employee. While Greenlight Biosciences Holdings Pbc's total ranking has deteriorated compared to the previous quarter from 0 to 4025.


What is Income per Employee Ratio?






GRNA Net Income per Employee (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,100,119 -1,168,217 -1,139,601 -883,438 -541,469
GRNA's Total Ranking # 4025 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


GRNA Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 77
Healthcare Sector # 689
Overall Market # 4025

Net Income per Employee Statistics
High Average Low
$ -21,150 $ -580,423 $ -1,168,217
(Jun 30 2021)   (Dec 31 2022)







Companies with similar Income per Employee for 12 month ending Mar 31 2023, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2023Number of Employees Mar 31 2023


Date modified: 2026-09-08T15:10:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.